欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
PL/H/0784/005
药品名称
Ospamox
活性成分
Amoxicillin trihydrate 57.0 mg/ml
剂型
Powder for oral suspension
上市许可持有人
Sandoz GMBH
参考成员国 - 产品名称
Poland (PL)
互认成员国 - 产品名称
许可日期
2009/08/27
最近更新日期
2024/12/30
药物ATC编码
J01CA04 amoxicillin
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final SPC
|
final_common_SPC_AT_H_0188_001_003_IB_022_clean
Date of last change:2024/09/06
Final SPC
|
final_common_SPC_AT_H_0188_003_006_IB_022_clean
Date of last change:2024/09/06
Final Labelling
|
LAB_final_AT_H_0187_188_189_IB_027_024_021_powder_for_oral_suspension_clean
Date of last change:2024/09/06
PubAR
|
PAR_AT_H_188_001_006_Amoxicillin Hexal Filmtabletten
Date of last change:2024/09/06
Final PL
|
PIL_final_AT_H_0187_188_189_IB_027_024_021_powder_for_oral_suspension_clean
Date of last change:2024/09/06
Final Product Information
|
SPC_final_AT_H_0187_188_189_IB_027_024_021_powder_for_oral_suspension_clean
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase